Vertex Pharmaceuticals Incorporated
VRTX NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Aug 3, 2026
ET
EPS Est.
4.74
EPS Actual
4.73
Revenue Est.
$3.23B
Revenue Actual
$3.33B
Next Earnings Report
Date
Nov 2, 2026 · Mon
ET Nov 2, 2026 · Mon
Time
11/2 21:00-11/3 01:00
After-market(ET)
Fiscal Period
FY2026 Q3
EPS Est.
4.76
Revenue Est.
$3.41B
Company Overview
Vertex Pharmaceuticals Incorporated (ticker VRTX) is listed on NASDAQ with a market cap of about $128.1B. Its next earnings report (FY2026 Q3) is expected on Nov 2, 2026 (ET), After-market, with consensus EPS of 4.76. In the last 15 reported quarters, EPS beat consensus estimates 10 times.
Actual EPS TrendRecently15Term · Feb 7, 2023 → Aug 3, 2026
Feb 7, 2023Range: -12.83 ~ 5.03Aug 3, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Aug 3, 2026 | -- | 4.74 | Below forecast↓4.73 | $3.23B | $3.33B |
| May 4, 2026 | -- | 4.24 | Above forecast↑4.47 | $2.99B | $2.99B |
| Feb 12, 2026 | -- | 5.11 | Below forecast↓5.03 | $3.18B | $3.19B |
| Nov 3, 2025 | -- | 4.57 | Above forecast↑4.80 | $3.06B | $3.08B |
| Aug 4, 2025 | -- | 4.29 | Above forecast↑4.52 | $2.91B | $2.96B |
| May 5, 2025 | -- | 4.25 | Below forecast↓4.06 | $2.86B | $2.77B |
| Feb 10, 2025 | -- | 4.02 | Below forecast↓3.98 | $2.78B | $2.91B |
| Nov 4, 2024 | -- | 4.14 | Above forecast↑4.38 | $2.69B | $2.77B |
| Aug 1, 2024 | -- | -11.63 | Below forecast↓-12.83 | $2.66B | $2.63B |
| May 6, 2024 | -- | 4.06 | Above forecast↑4.76 | $2.58B | $2.69B |
| Feb 5, 2024 | -- | 4.10 | Above forecast↑4.20 | $2.51B | $2.52B |
| Nov 6, 2023 | -- | 3.97 | Above forecast↑4.08 | $2.5B | $2.48B |
| Aug 1, 2023 | -- | 3.88 | Above forecast↑3.89 | $2.42B | $2.49B |
| May 1, 2023 | -- | 3.00 | Above forecast↑3.05 | $2.34B | $2.37B |
| Feb 7, 2023 | -- | 3.51 | Above forecast↑3.76 | $2.3B | $2.3B |
Original Filings (SEC)
Quarterly10-Q · 2026-08-04 ↗
Earnings Release8-K · 2026-08-03 ↗
Quarterly10-Q · 2026-05-05 ↗
Earnings Release8-K · 2026-05-04 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
